-+ 0.00%
-+ 0.00%
-+ 0.00%

INTENSITY THERAPEUTICS, INC. RESTARTS PATIENT TREATMENT IN THE RANDOMIZED, PRESURGICAL TRIPLE NEGATIVE BREAST CANCER PHASE 2 CLINICAL TRIAL (INVINCIBLE-4 STUDY)

Reuters·07/15/2026 11:45:00

Please log in to view news